Abstract

The effectiveness of a bedside filter (Sepacell R 500A) for removing leukocytes was evaluated in vitro at a flow rate of 5ml per minute using two red blood cell products; normal concentrated red cells (N-CRC) and buffy coat depleted concentrated red cells (BD-CRC), stored for 5 and 10 days after blood collection, respectively.Whole blood 400ml was collected from healthy donors in a triple-bag or a quadruple-bag containing 56ml of citrate-phosphate-dextrose. Within 6 hours of collection, the blood was centrifuged at 1300×g for 6min in a Kubota 9810 centrifuge. The blood collected in a triple-bag was separated into platelet-rich plasma and concentrated red cells (N-CRC). The blood collected in a quadruple-bag was separated into platelet-rich plasma, a buffy coat and concentrated red cells (BD-CRC).Two bags of N-CRC and two bags of BD-CRC on the 5th day after blood collection were each filtered using one filter. Residual leukocytes were 5-61×107 cells and 0.3-14×107 cells, respectively. Two bags of N-CRC and two bags of BD-CRC on the 10th day were each filtered using one filter. Residual leukocytes were 1-11×107 cells and 0-0.5×10' cells, respectively. Red cell recovery was 84-93% when two bags were used with the same filter.After filtration of BD-CRC through the bedside filter, the residual leukocytes were lower than the results obtained from N-CRC, because about 75% of the leukocytes were removed with the buffy coat before filtration. This method may be effective for preventing the production of antileukocyte antibodies.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call